These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39539970)

  • 1. Stimuli-Responsive Peptide/siRNA Nanoparticles as a Radiation Sensitizer for Glioblastoma Treatment by Co-Inhibiting RELA/P65 and EGFR.
    Cen B; Zhang J; Pan X; Xu Z; Li R; Chen C; Wang B; Li Z; Zhang G; Ji A; Yuan Y
    Int J Nanomedicine; 2024; 19():11517-11537. PubMed ID: 39539970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
    He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
    Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo.
    Kozielski KL; Ruiz-Valls A; Tzeng SY; Guerrero-Cázares H; Rui Y; Li Y; Vaughan HJ; Gionet-Gonzales M; Vantucci C; Kim J; Schiapparelli P; Al-Kharboosh R; Quiñones-Hinojosa A; Green JJ
    Biomaterials; 2019 Jul; 209():79-87. PubMed ID: 31026613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.
    Kievit FM; Wang K; Ozawa T; Tarudji AW; Silber JR; Holland EC; Ellenbogen RG; Zhang M
    Nanomedicine; 2017 Oct; 13(7):2131-2139. PubMed ID: 28614736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma.
    Michiue H; Eguchi A; Scadeng M; Dowdy SF
    Cancer Biol Ther; 2009 Dec; 8(23):2306-13. PubMed ID: 19901546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment.
    Cho HJ; Chong S; Chung SJ; Shim CK; Kim DD
    Pharm Res; 2012 Apr; 29(4):1007-19. PubMed ID: 22169985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer.
    Reda M; Ngamcherdtrakul W; Gu S; Bejan DS; Siriwon N; Gray JW; Yantasee W
    Cancer Lett; 2019 Dec; 467():9-18. PubMed ID: 31563561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
    Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
    Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.
    Xu Q; Hu C; Zhu Y; Wang K; Lal B; Li L; Tang J; Wei S; Huang G; Xia S; Lv S; Laterra J; Jiang Y; Li Y
    Cancer Lett; 2020 Jul; 482():126-135. PubMed ID: 31954770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
    Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling.
    Qiu H; Shao Z; Wen X; Qu D; Liu Z; Chen Z; Zhang X; Ding X; Zhang L
    J Transl Med; 2024 Jul; 22(1):688. PubMed ID: 39075517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
    Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
    Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells.
    Lou B; Connor K; Sweeney K; Miller IS; O'Farrell A; Ruiz-Hernandez E; Murray DM; Duffy GP; Wolfe A; Mastrobattista E; Byrne AT; Hennink WE
    Drug Deliv Transl Res; 2019 Jun; 9(3):679-693. PubMed ID: 30972664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
    Van Woensel M; Wauthoz N; Rosière R; Mathieu V; Kiss R; Lefranc F; Steelant B; Dilissen E; Van Gool SW; Mathivet T; Gerhardt H; Amighi K; De Vleeschouwer S
    J Control Release; 2016 Apr; 227():71-81. PubMed ID: 26902800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic Nanosensitizer Potentiates Efficient Glioblastoma Gene-Radiotherapy through Synergistic Hypoxia Mitigation and PLK1 Silencing.
    Chen J; Cui J; Jiao B; Zheng Z; Yu H; Wang H; Zhang G; Lai S; Gan Z; Yu Q
    ACS Appl Mater Interfaces; 2024 Oct; 16(43):58241-58261. PubMed ID: 39287499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
    Hadjipanayis CG; Machaidze R; Kaluzova M; Wang L; Schuette AJ; Chen H; Wu X; Mao H
    Cancer Res; 2010 Aug; 70(15):6303-12. PubMed ID: 20647323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
    Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
    J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.
    Wang K; Park JO; Zhang M
    J Gene Med; 2013 Jan; 15(1):42-50. PubMed ID: 23319157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
    Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
    J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.